Dr. Michael (Mick) Murray is interested in improving medication uses and safety in individuals with chronic diseases and on factors affecting patient adherence to their chronic medications. His research focuses on developing pharmacy services to improve drug therapy in older adults with chronic disorders, medication safety, improving the quality of health of low-income minority people, and pharmacoepidemiology using large population computer databases.
Dr. Murray is a member of the National Academy of Medicine’s Clinical Effectiveness Research Innovation Collaborative and the World Health Organization’s committee for Global Patient Safety Challenge on Medication Safety. He has served on the boards of the American Society for Clinical Pharmacology & Therapeutics, the International Society for Pharmacoepidemiology (in which he is a fellow and charter member), and the United States Pharmacopeia.
He earned his PharmD from Duquesne University and an MPH from Indiana University.